Scarica l'app Stockscreener
0.2175
14.47%
0.0275
Dopo l'orario di chiusura:
.22
0.0025
+1.15%
Geovax Labs Inc Borsa (GOVX) Ultime notizie
How GeoVax Labs Inc. stock reacts to bond yieldsStock Split Announcements & Free Risk Assessment and Control - bollywoodhelpline.com
GeoVax Labs to Outline Clinical Progress and Strategic Priorities at Major Healthcare Conferences - citybuzz -
GeoVax Labs, Inc. to Review Progress and Strategic Priorities During Biotech Showcase 2026 and J.P. Morgan Healthcare Conference Week - Yahoo Finance
Is GeoVax Labs Inc. Equity Warrant stock safe for conservative investors2026 world cup usa national team round of 16 young talents build up play odds analysis preview - Улправда
Why GeoVax Labs Inc. stock appeals to dividend seekers2026 world cup usa national team quarterfinals key players counter attacking expert forecast analysis - Улправда
GeoVax shareholders approve warrant exercises - MSN
GOVX News Today | Why did GeoVax Labs stock drop today? - MarketBeat
GeoVax Labs (NASDAQ:GOVX) Shares Up 21.1% – Should You Buy? - Defense World
Is GeoVax Labs Inc a good long term investmentSupport Level Holds & Big Returns Small Capital - earlytimes.in
Sentiment Watch: Why GeoVax Labs Inc stock is favored by top institutionsQuarterly Performance Summary & Real-Time Market Sentiment Reports - moha.gov.vn
GeoVax Labs Inc Equity Warrant Stock Analysis and ForecastDividend Yield Trends & Best Stocks For Explosive Growth - earlytimes.in
Analyst Calls: What dividend safety score for GeoVax Labs Inc Equity Warrant stockQuarterly Trade Report & AI Powered Market Entry Ideas - moha.gov.vn
GeoVax Labs announces public equity offering for liquidity - MSN
Is Now the Best Entry Point for Orient Cement Limited StockCovered Call Writing & Fast Profit Strategies - earlytimes.in
GeoVax Labs Announces Public Equity Offering for Liquidity - The Globe and Mail
GeoVax Labs Signs Multiple Material Agreements - TradingView — Track All Markets
Market Wrap: Can GeoVax Labs Inc stock deliver sustainable ROE2025 Price Momentum & Expert Approved Momentum Ideas - moha.gov.vn
Why GeoVax Labs Inc. stock is recommended by analystsQuarterly Earnings Report & Proven Capital Preservation Methods - Улправда
Is GeoVax Labs Inc. stock a bargain at current levelsJuly 2025 Closing Moves & Safe Investment Capital Preservation Plans - Улправда
Can GeoVax Labs Inc. stock sustain institutional interestGold Moves & Fast Moving Trade Plans - Улправда
Analyst Downgrade: How GeoVax Labs Inc. Equity Warrant stock reacts to inflationary pressuresJuly 2025 Decliners & Accurate Entry and Exit Point Alerts - Улправда
Why GeoVax Labs Inc. stock is a must watch in 20252025 Market Overview & Stock Portfolio Risk Management - Улправда
Geovax Labs Stock Slides 61% With A 9-Day Losing Spree - Trefis
Will GeoVax Labs Inc. stock outperform Nasdaq indexPrice Action & Free Low Drawdown Momentum Trade Ideas - Улправда
GeoVax Announces $3.2 Million Public Offering to Fund Clinical-Stage Vaccine and Cancer Therapy Development - citybuzz -
Why GeoVax Labs Inc. stock attracts global investors2025 Market WrapUp & Weekly Return Optimization Alerts - Улправда
Dow Gains Over 200 Points; Conagra Shares Fall After Q2 Results - Sahm
What dividend safety score for GeoVax Labs Inc. Equity Warrant stock2025 Trade Ideas & Risk Managed Trade Strategies - DonanımHaber
GeoVax to Raise Approximately $3.2 Million of Gross Proceeds in Public Offering - Yahoo Finance
How GeoVax Labs Inc. Equity Warrant stock responds to policy changesJuly 2025 Closing Moves & Daily Oversold Stock Bounce Ideas - DonanımHaber
How GeoVax Labs Inc. stock performs after earnings2025 Support & Resistance & Verified Technical Trade Signals - DonanımHaber
Why GeoVax Labs Inc. stock is popular among millennialsJuly 2025 Chart Watch & Risk Controlled Stock Pick Alerts - Улправда
Is GeoVax Labs Inc. Equity Warrant stock attractive for growth ETFs2025 Earnings Surprises & Fast Gaining Stock Strategy Reports - DonanımHaber
Can GeoVax Labs Inc. Equity Warrant stock beat market expectations this quarterMarket Sentiment Summary & Weekly Return Optimization Plans - DonanımHaber
Why GeoVax Labs Inc. stock remains a top recommendationDip Buying & AI Powered Buy and Sell Recommendations - DonanımHaber
Why GeoVax Labs Inc. Equity Warrant stock could be next big winner2025 Big Picture & Daily Entry Point Trade Alerts - Улправда
How currency fluctuations impact GeoVax Labs Inc. stockCPI Data & Weekly Setup with ROI Potential - Улправда
Market Rankings: Can GeoVax Labs Inc. stock sustain institutional interestJuly 2025 Pullbacks & Real-Time Volume Spike Alerts - Улправда
Market Review: Why GeoVax Labs Inc. stock is a must watch in 20252025 Performance Recap & Capital Efficiency Focused Ideas - Улправда
GeoVax Receives EMA Scientific Advice for Phase 3 Trial of Mpox and Smallpox Vaccine Candidate - citybuzz -
GeoVax Announces Publication of Study Demonstrating Cross-Variant Protection Using the Multi-Antigen GEO-CM04S1 Vaccine - Yahoo Finance
GeoVax Receives Formal EMA Scientific Advice Supporting Pivotal Phase 3 Immunobridging Trial for GEO-MVA - Yahoo Finance
Sentiment Watch: Why GeoVax Labs Inc. stock appeals to dividend seekersJuly 2025 Decliners & AI Forecast Swing Trade Picks - ulpravda.ru
GeoVax Advances Domestic Mpox Vaccine Production with Manufacturing Milestone - citybuzz -
GeoVax Announces Completion of GEO-MVA Fill-Finish, Supporting Phase 3 Immunobridging Clinical Trial Start-Up in Early 2026 - Yahoo Finance
Geovax Labs Inc (GOVX) stock: A year of ups and downs - uspostnews.com
GeoVax Receives U.S. Patent Office Notice of Allowance for Broad-Spectrum COVID-19 Vaccine Design - Yahoo Finance
GeoVax’s Next-Generation COVID-19 Vaccine Shows Superior T-Cell Response in CLL Patients, Trial Advances Exclusively – citybuzz - citybuzz
GeoVax Announces British Journal of Haematology Publication Highlighting Superior T-Cell Responses of GEO-CM04S1 in CLL Patients - Yahoo Finance
What drives GeoVax Labs Inc stock priceMarket Breadth Indicators & Buy Sell Timing Alerts - earlytimes.in
Published on: 2025-12-15 02:46:59 - earlytimes.in
New Mpox Variant Emergence Highlights Global Vaccine Supply Vulnerability, GeoVax Accelerates Domestic Alternative – citybuzz - citybuzz
GeoVax Addresses Identification of New Mpox Variant - TradingView — Track All Markets
GeoVax Strengthens Scientific Advisory Board with Global Vaccine Experts - citybuzz
GeoVax Announces Addition of Renowned Global Experts to Its Scientific Advisory Board - Yahoo Finance
GeoVax Announces Issuance of U.S. Patent Covering Enhanced Therapeutic Use of Gedeptin(R) Gene Therapy - Yahoo Finance
GeoVax’s Gedeptin Shows Favorable Safety and Disease Stability in Recurrent Head & Neck Cancer Trial - citybuzz
GeoVax Announces JCO Oncology Advances Publication Highlighting Favorable Safety and Evidence of Disease Stability of Gedeptin(R) in Recurrent Head & Neck Cancer - Yahoo Finance
2.52%
0.07%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):